Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The partnership grants Chromocell access to concentrate on the clinical advancement of a sublingual formulation of a Diclofenac spray designed for treating acute pain.
Lead Product(s): Diclofenac
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: Phase IProduct Type: Small molecule
Partner/Sponsor/Collaborator: Chromocell Corporation
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership February 27, 2024
Details:
Radius Health has acquired the global development and commercialization rights to Benuvia Therapeutics' RAD011, a pivotal-trial ready synthetic cannabidiol oral solution with potential utilization in multiple endocrine and metabolic orphan diseases.
Lead Product(s): Cannabidiol
Therapeutic Area: Genetic Disease Product Name: RAD011
Highest Development Status: Phase IIProduct Type: Small molecule
Partner/Sponsor/Collaborator: Radius Health
Deal Size: $72.5 million Upfront Cash: Undisclosed
Deal Type: Acquisition January 06, 2021